Drug control authorities from Uttar Pradesh and Himachal Pradesh have uncovered an illegal pharmaceutical manufacturing operation at Rajpura in Nalagarh, where medicines were allegedly being produced under the names of reputed pharmaceutical companies. Three people have been detained, while drug manufacturing and packaging machinery has been seized during the enforcement operation.
Investigators have also identified two suspected unlicensed manufacturing facilities in the Baddi area, expanding the scope of the investigation.
How Was the Racket Uncovered?
The operation was initiated following specific intelligence inputs received from the State Drugs Controller of the Uttar Pradesh Food and Drugs Administration (FDA) regarding suspected illegal pharmaceutical manufacturing activities in Himachal Pradesh.
Acting on the information, a team comprising police personnel and drug inspectors from Uttar Pradesh travelled to Himachal Pradesh to coordinate with the state’s Drugs Control Administration. Dedicated investigation teams were subsequently formed to conduct joint enforcement operations at the suspected premises.
FCRF Launches Certified Chief Risk Officer (CRO) Program for India’s Risk Leaders
An investigating team comprising drug inspectors Suresh, Akshay, Harish and Promila conducted a raid at the manufacturing facility in Rajpura on Wednesday evening. During the inspection, officials found that pharmaceutical formulations bearing the names of other companies were allegedly being manufactured at the premises.
Authorities immediately began seizing machinery, suspected spurious medicines and other relevant material. The seized items and evidence are being examined to determine the extent of the illegal manufacturing activities and identify those involved.
What Did Investigators Find in Baddi?
During the investigation, authorities received further intelligence regarding similar suspected illegal drug manufacturing activities at two other premises in the Baddi area.
Investigation teams visited both locations but found the premises locked, with no individuals present at either site. With assistance from the local police, authorities deployed security personnel at both locations to prevent the removal of materials or tampering with potential evidence.
Himachal Pradesh State Drugs Controller Dr Manish Kapoor has constituted two additional investigation teams to examine the suspected unlicensed facilities and undertake further enforcement action.
Authorities are investigating the activities at these premises to establish whether they are connected to the illegal manufacturing operation uncovered in Nalagarh.
How Extensive Is the Illegal Drug Network?
According to Dr Kapoor, the investigation is not restricted to the seizure of suspected spurious medicines. Authorities are also seeking to identify and dismantle the wider network involved in the illegal manufacturing, procurement, distribution and supply of pharmaceutical products.
The discovery of medicines allegedly manufactured under the names of established pharmaceutical companies raises concerns about the authenticity of products entering pharmaceutical distribution channels.
While three individuals have been detained, the full scale of the operation, the quantity of medicines manufactured and the extent of their distribution remain unclear.
The drug control authorities of both states are continuing their investigation to identify other individuals and establishments potentially involved in the illegal pharmaceutical supply network.
